Skip to main content
. 2022 May 25;18:100416. doi: 10.1016/j.lanepe.2022.100416

Table 1.

Baseline demographics, comorbidities and diuretic use in people newly diagnosed with gout, separated by sex. Data are presented as mean (standard deviation) for continuous measures, and n (%) for categorical measures. CKD: chronic kidney disease; TIA: transient ischaemic attack. Baseline serum urate levels were available for 80,054 patients (male patients: n = 56,963; female patients: n=23,091).

Total Male Female
N = 129,972 N = 94,610 N = 35,362
Age at diagnosis, years 62 (15) 59 (15) 69 (14)
Country:
 England 69,129 (53.2%) 50,897 (53.8%) 18,232 (51.6%)
 Wales 28,180 (21.7%) 20,387 (21.5%) 7793 (22.0%)
 Scotland 26,154 (20.1%) 18,706 (19.8%) 7448 (21.1%)
 Northern Ireland 6509 (5.0%) 4620 (4.9%) 1889 (5.3%)
Number of comorbidities at diagnosis 1.5 (1.4) 1.3 (1.3) 2.0 (1.4)
CKD stages 3-5
 No 97,103 (74.7%) 76,665 (81.0%) 20,438 (57.8%)
 Yes 32,869 (25.3%) 17,945 (19.0%) 14,924 (42.2%)
Hypertension
 No 68,106 (52.4%) 55,387 (58.5%) 12,719 (36.0%)
 Yes 61,866 (47.6%) 39,223 (41.5%) 22,643 (64.0%)
Diabetes mellitus
 No 114,309 (87.9%) 85,144 (90.0%) 29,165 (82.5%)
 Yes 15,663 (12.1%) 9466 (10.0%) 6197 (17.5%)
Ischaemic heart disease
 No 109,817 (84.5%) 80,348 (84.9%) 29,469 (83.3%)
 Yes 20,155 (15.5%) 14,262 (15.1%) 5893 (16.7%)
Heart failure
 No 121,084 (93.2%) 88,836 (93.9%) 32,248 (91.2%)
 Yes 8888 (6.8%) 5774 (6.1%) 3114 (8.8%)
Previous stroke or TIA
 No 122,200 (94.0%) 89,570 (94.7%) 32,630 (92.3%)
 Yes 7772 (6.0%) 5040 (5.3%) 2732 (7.7%)
Obesity
 No 79,364 (61.1%) 60,044 (63.5%) 19,320 (54.6%)
 Yes 50,608 (38.9%) 34,566 (36.5%) 16,042 (45.4%)
Urolithiasis
 No 127,259 (97.9%) 92,432 (97.7%) 34,827 (98.5%)
 Yes 2713 (2.1%) 2178 (2.3%) 535 (1.5%)
Current/ex-smoker
 No 48,550 (37.4%) 34,953 (36.9%) 13,597 (38.5%)
 Yes 81,422 (62.6%) 59,657 (63.1%) 21,765 (61.5%)
Alcohol excess
 No 121,975 (93.8%) 87,823 (92.8%) 34,152 (96.6%)
 Yes 7997 (6.2%) 6787 (7.2%) 1210 (3.4%)
Diuretic therapy
 No 82,986 (63.8%) 67,916 (71.8%) 15,070 (42.6%)
 Yes 46,986 (36.2%) 26,694 (28.2%) 20,292 (57.4%)
Baseline serum urate level, µmol/L 472 480 452